HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cells.


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
03 2020
Historique:
received: 11 01 2019
accepted: 28 12 2019
pubmed: 19 2 2020
medline: 21 4 2020
entrez: 19 2 2020
Statut: ppublish

Résumé

Human immunodeficiency virus 1 (HIV-1) infection is associated with heightened inflammation and excess risk of cardiovascular disease, cancer and other complications. These pathologies persist despite antiretroviral therapy. In two independent cohorts, we found that innate lymphoid cells (ILCs) were depleted in the blood and gut of people with HIV-1, even with effective antiretroviral therapy. ILC depletion was associated with neutrophil infiltration of the gut lamina propria, type 1 interferon activation, increased microbial translocation and natural killer (NK) cell skewing towards an inflammatory state, with chromatin structure and phenotype typical of WNT transcription factor TCF7-dependent memory T cells. Cytokines that are elevated during acute HIV-1 infection reproduced the ILC and NK cell abnormalities ex vivo. These results show that inflammatory cytokines associated with HIV-1 infection irreversibly disrupt ILCs. This results in loss of gut epithelial integrity, microbial translocation and memory NK cells with heightened inflammatory potential, and explains the chronic inflammation in people with HIV-1.

Identifiants

pubmed: 32066947
doi: 10.1038/s41590-020-0593-9
pii: 10.1038/s41590-020-0593-9
pmc: PMC7044076
mid: NIHMS1547618
doi:

Substances chimiques

Cytokines 0
T Cell Transcription Factor 1 0
TCF7 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

274-286

Subventions

Organisme : NIH HHS
ID : P51 OD011092
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI096109
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI042845
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001453
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI111809
Pays : United States
Organisme : NIAID NIH HHS
ID : R24 AI067039
Pays : United States
Organisme : NIDA NIH HHS
ID : DP1 DA034990
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK105837
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027763
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI119885
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG007910
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI147868
Pays : United States
Organisme : NIH HHS
ID : S10 OD025002
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Deeks, S. G., Tracy, R. & Douek, D. C. Systemic effects of inflammation on health during chronic HIV infection. Immunity 39, 633–645 (2013).
pubmed: 24138880 pmcid: 4012895
Brenchley, J. M. et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365–1371 (2006).
pubmed: 17115046
Vivier, E. et al. Innate lymphoid cells: 10 years on. Cell 174, 1054–1066 (2018).
Kløverpris, H. N. et al. Innate lymphoid cells are depleted irreversibly during acute HIV-1 infection in the absence of viral suppression. Immunity 44, 391–405 (2016).
pubmed: 26850658 pmcid: 6836297
Mudd, J. C. et al. Hallmarks of primate lentiviral immunodeficiency infection recapitulate loss of innate lymphoid cells. Nat. Commun. 9, 3967 (2018).
pubmed: 30262807 pmcid: 6160474
Bruel, T. et al. Elimination of HIV-1-infected cells by broadly neutralizing antibodies. Nat. Commun. 7, 10844 (2016).
pubmed: 26936020 pmcid: 4782064
Alter, G. et al. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 476, 96–100 (2011).
pubmed: 21814282 pmcid: 3194000
Cerwenka, A. & Lanier, L. L. Natural killer cell memory in infection, inflammation and cancer. Nat. Rev. Immunol. 16, 112–123 (2016).
pubmed: 26806484
Lim, A. I. et al. Systemic human ILC precursors provide a substrate for tissue ILC differentiation. Cell 168, 1086–1100.e10 (2017).
pubmed: 28283063
Colonna, M. Innate lymphoid cells: diversity, plasticity, and unique functions in immunity. Immunity 48, 1104–1117 (2018).
pubmed: 29924976 pmcid: 6344351
Mazzucchelli, R. & Durum, S. K. Interleukin-7 receptor expression: intelligent design. Nat. Rev. Immunol. 7, 144–154 (2007).
pubmed: 17259970
Leonard, W. J. & O’Shea, J. J. JAKS and STATs: biological implications. Annu. Rev. Immunol. 16, 293–322 (1998).
pubmed: 9597132
Mavilio, D. et al. Characterization of CD56
pubmed: 15699323
Fang, M. et al. CD94 is essential for NK cell-mediated resistance to a lethal viral disease. Immunity 34, 579–589 (2011).
pubmed: 21439856 pmcid: 3081423
Jeevan-Raj, B. et al. The transcription factor Tcf1 contributes to normal NK cell development and function by limiting the expression of granzymes. Cell Rep. 20, 613–626 (2017).
pubmed: 28723565
Wendel, M., Galani, I. E., Suri-Payer, E. & Cerwenka, A. Natural killer cell accumulation in tumors is dependent on IFN-γ and CXCR3 ligands. Cancer Res. 68, 8437–8445 (2008).
pubmed: 18922917
Sconocchia, G., Titus, J. A. & Segal, D. M. Signaling pathways regulating CD44-dependent cytolysis in natural killer cells. Blood 90, 716–725 (1997).
pubmed: 9226172
Liu, L. L. et al. Critical role of CD2 co-stimulation in adaptive natural killer cell responses revealed in NKG2C-deficient humans. Cell Rep. 15, 1088–1099 (2016).
pubmed: 27117418 pmcid: 4858565
Juelke, K. et al. CD62L expression identifies a unique subset of polyfunctional CD56
pubmed: 20505160
Gazit, R. et al. Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome. Blood 103, 1965–1966 (2004).
pubmed: 14976061
Klein, A. M. et al. Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells. Cell 161, 1187–1201 (2015).
pubmed: 26000487 pmcid: 4441768
Tibshirani, R. & Walther, G. Cluster validation by prediction strength. J. Comput. Graph. Stat. 14, 511–528 (2005).
Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381–386 (2014).
pubmed: 4122333 pmcid: 4122333
Utzschneider, D. T. et al. T cell factor 1-expressing memory-like CD8
pubmed: 27533016
Jeannet, G. et al. Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory. Proc. Natl Acad. Sci. USA 107, 9777–9782 (2010).
pubmed: 20457902
Yang, Q. et al. TCF-1 upregulation identifies early innate lymphoid progenitors in the bone marrow. Nat. Immunol. 16, 1044–1050 (2015).
pubmed: 26280998 pmcid: 4575643
Aksoy, I. et al. Self-renewal of murine embryonic stem cells is supported by the serine/threonine kinases Pim-1 and Pim-3. Stem Cells 25, 2996–3004 (2007).
pubmed: 17717068
Baaten, B. J. G. et al. CD44 regulates survival and memory development in Th1 cells. Immunity 32, 104–115 (2010).
pubmed: 20079666 pmcid: 2858628
Weng, N.-P., Araki, Y. & Subedi, K. The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation. Nat. Rev. Immunol. 12, 306–315 (2012).
pubmed: 22421787 pmcid: 4686144
Moretta, L. Dissecting CD56
pubmed: 21071612
Paust, S. et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat. Immunol. 11, 1127–1135 (2010).
pubmed: 20972432 pmcid: 2982944
Roychoudhuri, R. et al. BACH2 regulates CD8
pubmed: 27158840 pmcid: 4918801
Shin, H. M. et al. Epigenetic modifications induced by Blimp-1 regulate CD8
pubmed: 24120360
Kamimura, Y. & Lanier, L. L. Homeostatic control of memory cell progenitors in the natural killer cell lineage. Cell Rep. 10, 280–291 (2015).
pubmed: 25578733 pmcid: 4359047
Brenchley, J. M. et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8
pubmed: 12433688
Wherry, E. J. et al. Molecular signature of CD8
pubmed: 17950003
Lin, W.-H. W. et al. CD8
pubmed: 27829149 pmcid: 5108530
Vigneau, S., Rohrlich, P.-S., Brahic, M. & Bureau, J.-F. Tmevpg1, a candidate gene for the control of Theiler’s virus persistence, could be implicated in the regulation of gamma interferon. J. Virol. 77, 5632–5638 (2003).
pubmed: 12719555 pmcid: 154023
Gomez, J. A. et al. The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-γ locus. Cell 152, 743–754 (2013).
pubmed: 23415224 pmcid: 3577098
Walker, W., Aste-Amezaga, M., Kastelein, R. A., Trinchieri, G. & Hunter, C. A. IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-γ. J. Immunol. 162, 5894–5901 (1999).
pubmed: 10229825
Schoenborn, J. R. & Wilson, C. B. Regulation of interferon‐γ during innate and adaptive immune responses. Adv. Immunol. 96, 41–101 (2007).
pubmed: 17981204
Björkström, N. K. et al. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56
pubmed: 20696944
Romee, R. et al. Cytokine activation induces human memory-like NK cells. Blood 120, 4751–4760 (2012).
pubmed: 22983442 pmcid: 3520618
Cooper, M. A. et al. Cytokine-induced memory-like natural killer cells. Proc. Natl Acad. Sci. USA 106, 1915–1919 (2009).
pubmed: 19181844
Henning, A. N., Roychoudhuri, R. & Restifo, N. P. Epigenetic control of CD8
pubmed: 29379213 pmcid: 6327307
Hu, G. & Chen, J. A genome-wide regulatory network identifies key transcription factors for memory CD8
pubmed: 24335726 pmcid: 3999894
O’Sullivan, T. E., Sun, J. C. & Lanier, L. L. Natural killer cell memory. Immunity 43, 634–645 (2015).
pubmed: 26488815 pmcid: 4621966
Xing, S. et al. Tcf1 and Lef1 transcription factors establish CD8
pubmed: 27111144 pmcid: 4873337
Thomas, R. et al. NKG2C deletion is a risk factor of HIV infection. AIDS Res. Hum. Retroviruses 28, 844–851 (2012).
pubmed: 22074011 pmcid: 3399562
Fregni, G. et al. High number of CD56
pubmed: 23351719 pmcid: 3568014
Davis, Z. B. et al. A conserved HIV-1-derived peptide presented by HLA-E renders infected T-cells highly susceptible to attack by NKG2A/CD94-bearing natural killer cells. PLoS Pathog. 12, e1005421 (2016).
pubmed: 26828202 pmcid: 4735451
Neri, S., Mariani, E., Meneghetti, A., Cattini, L. & Facchini, A. Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants. Clin. Diagn. Lab. Immunol. 8, 1131–1135 (2001).
pubmed: 11687452 pmcid: 96238
Pertel, T. et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472, 361–365 (2011).
pubmed: 21512573 pmcid: 3081621
Poli, A. et al. CD56
pubmed: 19278419 pmcid: 2673358
Hashimshony, T. et al. CEL-Seq2: sensitive highly-multiplexed single-cell RNA-Seq. Genome Biol. 17, 77 (2016).
pubmed: 27121950 pmcid: 4848782
Skene, P. J. & Henikoff, S. An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites. Elife 6, e21856 (2017).
pubmed: 28079019 pmcid: 5310842
Hainer, S. J., Boskovic, A., Rando, O. J. & Fazzio, T. G. Profiling of pluripotency factors in individual stem cells and early embryos. Cell 177, 1319–1329.e11 (2019).
pubmed: 30955888
Skene, P. J., Henikoff, J. G. & Henikoff, S. Targeted in situ genome-wide profiling with high efficiency for low cell numbers. Nat. Protoc. 13, 1006–1019 (2018).
pubmed: 29651053
Buenrostro, J. D., Wu, B., Chang, H. Y. & Greenleaf, W. J. ATAC-Seq: a method for assaying chromatin accessibility genome-wide. Curr. Protoc. Mol. Biol. 109, 21.29.1–21.29.9 (2015).
Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213–1218 (2013).
pubmed: 3959825 pmcid: 3959825
Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).
pubmed: 23618408 pmcid: 23618408
Derr, A. et al. End Sequence Analysis Toolkit (ESAT) expands the extractable information from single-cell RNA-Seq data. Genome Res. 26, 1397–1410 (2016).
pubmed: 27470110 pmcid: 5052061
Love, M., Anders, S. & Huber, W. Differential analysis of count data—the DESeq2 package. Genome Biol. 15, 550 (2014).
pubmed: 25516281 pmcid: 4302049
Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25 (2010).
pubmed: 20196867 pmcid: 2864565
Hyvärinen, A. & Oja, E. Independent component analysis: algorithms and applications. Neural Netw. 13, 411–430 (2000).
pubmed: 10946390
Hechenbichler, K. & Schliep, K. Weighted k-Nearest-Neighbor Techniques and Ordinal Classification Discussion Paper 399 (Ludwig-Maximilians-Universität München Collaborative Reseach Center 386, 2004).
Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).
Van Der Maaten, L. Accelerating t-SNE using tree-based algorithms. J. Mach. Learn. Res. 15, 3221–3245 (2014).
Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
pubmed: 2592715 pmcid: 2592715
Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24–26 (2011).
pubmed: 3346182 pmcid: 3346182

Auteurs

Yetao Wang (Y)

Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Lawrence Lifshitz (L)

Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Kyle Gellatly (K)

Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA, USA.

Carol L Vinton (CL)

Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Kathleen Busman-Sahay (K)

Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, USA.

Sean McCauley (S)

Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Pranitha Vangala (P)

Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA, USA.

Kyusik Kim (K)

Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Alan Derr (A)

Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA, USA.

Smita Jaiswal (S)

Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Alper Kucukural (A)

Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA, USA.

Patrick McDonel (P)

Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA, USA.

Peter W Hunt (PW)

Department of Medicine, University of California, San Francisco, CA, USA.

Thomas Greenough (T)

Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

JeanMarie Houghton (J)

Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Ma Somsouk (M)

Department of Medicine, University of California, San Francisco, CA, USA.

Jacob D Estes (JD)

Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, USA.

Jason M Brenchley (JM)

Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Manuel Garber (M)

Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA, USA.

Steven G Deeks (SG)

Department of Medicine, University of California, San Francisco, CA, USA.

Jeremy Luban (J)

Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA. jeremy.luban@umassmed.edu.
Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA. jeremy.luban@umassmed.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH